Search - tctmd.com

Presenter: Thomas J. Povsic, John P. Vavalle, Laura H. Aberle, Steven L. Zelenkofske, Roxana Mehran, Mauricio G. Cohen, Christopher E. Buller, Jan H. Cornel, Jaroslaw D. Kasprzak, Gilles Montalescot, Peter Fail, Ian J. Sarembock, John H. Alexander

January 03, 2012

News Daily News

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

October 31, 2011

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

News Daily News

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Jason Kahn

July 25, 2011

News Daily News

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

Jason Kahn

July 18, 2011

News Daily News

PCI Feasible Even in CAD Patients with End-Stage Liver Disease

July 15, 2011

News Daily News

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

L.A. McKeown

April 15, 2011

News Daily News

PES Show Delayed Healing in STEMI Patients, Clinical Significance Downplayed

Jason Kahn

January 12, 2011

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2010

Jason Kahn

January 02, 2011

Advertisement

HORIZONS-AMI: Más Consecuencias Cuando la Trombosis del Stent es Intrahospitalaria

ROCKET AF: Stopping Rivaroxaban or Warfarin Equally Harmful in A-fib Patients

ROCKET AF: Interrumpir la Toma de Rivaroxaban o Warfarina es Igual de Perjudicial en Pacientes con Fibrilación Auricular

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

In-Hospital Bleeding, Mortality Linked Long After NSTEMI

Relación Hemorragia Intrahospitalaria/Mortalidad tras Sufrir un NSTEMI

Restenotic Pattern After Femoropopliteal Stenting Predicts Recurrence

El Patrón Re-estenótico tras Colocación de Stent Femoropoplíteo Predice la Recurrencia

Younger Women with AMI Less Likely to Present with Chest Pain Than Men

BRIDGE Published: Cangrelor Promising Option as Bridging Therapy

Use of the REG1 Anticoagulation System During PCI May Improve Bleeding and Ischemic Complications Compared with Heparin: A PCI Substudy from the Phase 2B RADAR Trial

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

Apixaban Increases Major Bleeding in High-Risk ACS Patients

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

PCI Feasible Even in CAD Patients with End-Stage Liver Disease

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

PES Show Delayed Healing in STEMI Patients, Clinical Significance Downplayed

TCTMD’s Top 10 Most Popular News Stories for 2010

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content